BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6117727)

  • 1. D-TRP5-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty.
    Laron Z; Kauli R; Zeev ZB; Comaru-Schally AM; Schally AV
    Lancet; 1981 Oct; 2(8253):955-6. PubMed ID: 6117727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience.
    Kauli R; Pertzelan A; Ben-Zeev Z; Lewin RP; Kaufman H; Schally AM; Schally AV; Laron Z
    Clin Endocrinol (Oxf); 1984 Apr; 20(4):377-87. PubMed ID: 6232020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LH and FSH responses to LH-releasing hormone (LH-RH) in girls with true precocious puberty treated with cyproterone acetate.
    Kauli R; Prager-Lewin R; Keret R; Laron Z
    Eur J Pediatr; 1977 Jul; 125(3):205-12. PubMed ID: 328285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth and precocious puberty.
    Chaussain JL; Couprie C; Lacaille F; Simon D; Job JC
    Acta Paediatr Scand Suppl; 1988; 347():38-43. PubMed ID: 2978196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 levels in children with precocious puberty treated with gonadotropin-releasing hormone analog without or in combination with cyproterone acetate.
    Verrotti A; Ferrari M; Sabatino G; Morgese G; Chiarelli F
    Gynecol Endocrinol; 1997 Aug; 11(4):243-50. PubMed ID: 9272420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. True precocious puberty complicating congenital adrenal hyperplasia: treatment with a luteinizing hormone-releasing hormone analog.
    Pescovitz OH; Comite F; Cassorla F; Dwyer AJ; Poth MA; Sperling MA; Hench K; McNemar A; Skerda M; Loriaux DL
    J Clin Endocrinol Metab; 1984 May; 58(5):857-61. PubMed ID: 6368580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of precocious puberty with LH-RH agonists. Multicenter study using D-Trp-6-LH-RH in a programmed-release form].
    Roger M; Chaussain JL; Bost M; Bozzola M; Colle M; Despert F; François R; Freycon F; Garandeau P; Malpuech G
    Rev Fr Gynecol Obstet; 1986 May; 81(5):297-305. PubMed ID: 2943013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ; Beardsworth DE; Loughlin JS; Crawford JD; Bode HH; Rivier J; Vale W; Kushner DC; Crigler JF; Crowley WF
    N Engl J Med; 1983 Nov; 309(21):1286-90. PubMed ID: 6415479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The LH response to LH releasing hormone in children with true isosexual precocious puberty treated with cyproterone acetate.
    Kauli R; Prager-Lewin R; Keret R; Laron Z
    Clin Endocrinol (Oxf); 1975 May; 4(3):305-11. PubMed ID: 1097137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic effectiveness of the gonadotropin releasing hormone analogue D-Trp-6-LHRH in the treatment of precocious puberty].
    Rodríguez Arnao MD; Rodríguez Sánchez MD; González Sicilia IG; Lorenzo Navarro L; Nieto Cuartero J; Schally AV; Rodríguez Arnao J; García Centenera JA; Gómez Pan A
    An Esp Pediatr; 1988 Dec; 29(6):445-51. PubMed ID: 2977533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH)].
    Couprie C; Roger M; Chaussain JL
    J Steroid Biochem; 1989 Oct; 33(4B):805-8. PubMed ID: 2532270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
    Manasco PK; Pescovitz OH; Feuillan PP; Hench KD; Barnes KM; Jones J; Hill SC; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)].
    Canlorbe P; Chaussain JL; Lahlou N; Roger M; Toublanc JE; Job JC
    Bull Acad Natl Med; 1988 Nov; 172(8):1091-8. PubMed ID: 2977732
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis and treatment of central precocious puberty--can final height be improved? German/Dutch Central Precocious Puberty Study Group.
    Sippell WG
    Horm Res; 1994; 41 Suppl 2():14-5. PubMed ID: 8088698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height.
    Comite F; Cassorla F; Barnes KM; Hench KD; Dwyer A; Skerda MC; Loriaux DL; Cutler GB; Pescovitz OH
    JAMA; 1986 May; 255(19):2613-6. PubMed ID: 3084811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of deslorelin dose in the treatment of central precocious puberty.
    Pescovitz OH; Barnes KM; Cutler GB
    J Clin Endocrinol Metab; 1991 Jan; 72(1):60-4. PubMed ID: 1898743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous gonadotrophin pulsatility and ovarian morphology in girls with central precocious puberty treated with cyproterone acetate.
    Stanhope R; Pringle PJ; Adams J; Jeffcoate SL; Brook CG
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):547-53. PubMed ID: 2935331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.